The first large-scale, long-term trial of a new strategy using combinations of very low-doses in one capsule, has demonstrated significantly improved control of high blood pressure -- the leading cause of heart attack and stroke.
from Top Health News -- ScienceDaily https://ift.tt/3jsVOZN
Post a Comment